Literature DB >> 15770500

Intragenic linkage disequilibrium structure of the human perilipin gene (PLIN) and haplotype association with increased obesity risk in a multiethnic Asian population.

Lu Qi1, E Shyong Tai, Chee Eng Tan, Haiqing Shen, Suok Kai Chew, Andrew S Greenberg, Dolores Corella, Jose M Ordovas.   

Abstract

Perilipin is a lipid droplet surface protein present in adipocytes and steroidogenic cells. We examined five common single nucleotide polymorphisms (SNPs) at the perilipin (PLIN) locus (PLIN 6209C>T, 10171A>T, 11482G>A, 13041A>G, and 14995A>T) to investigate their association with obesity risk. The study population included 4,131 subjects of three ethnic groups (Chinese, Malay, and Indian) from Singapore. The prevalence of obesity in Malays and Indians was much higher than in Chinese. Moreover, in these groups the prevalence of obesity was three times higher in women than in men. Crude analysis indicated that haplotype 11212 (CAAAT) is shared by Malays and Indians and is significantly associated with increased obesity risk as compared to the most common haplotype 21111 (TAGAA): OR 1.65 (95% CI 1.11-2.46) in Malays and 1.94 (95% CI 1.06-3.53) in Indians. No associations between PLIN haplotypes and obesity risk were found in Chinese. To simplify the haplotype analyses we used a subgroup of three SNPs (11482G>A, 13041A>G, and 14995A>T) in positive linkage disequilibrium. These analyses revealed similar associations, showing that haplotypes XX212 (XXAAT) and XX222 (XXAGT) are associated with increased obesity risk in Malays OR 2.04 (95% CI 1.28-3.25) and 2.05 (95% CI 1.35-3.12) respectively, and that haplotype XXX212 (XXAAT) is significantly associated with increased obesity risk in Indians OR 2.16 (95% CI 1.10-4.26) after adjusting for covariates including age, sex, smoking, alcohol consumption, exercise, and diabetes status. Moreover, individual SNP analyses demonstrated that the PLIN 14995A>T SNP is the most informative single genetic marker for the observed haplotype association, being significantly associated with increased obesity risk in both Malays OR 2.28 (95% CI 1.45-3.57) and Indians OR 2.04 (95% CI 1.08-3.64). These results support the role of the PLIN locus as an ethnically dependent modulator of obesity risk in humans.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15770500     DOI: 10.1007/s00109-004-0630-4

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  21 in total

1.  Low body mass index but high percent body fat in Taiwanese subjects: implications of obesity cutoffs.

Authors:  C-J Chang; C-H Wu; C-S Chang; W-J Yao; Y-C Yang; J-S Wu; F-H Lu
Journal:  Int J Obes Relat Metab Disord       Date:  2003-02

2.  Specific haplotypes of the P-selectin gene are associated with myocardial infarction.

Authors:  David-Alexandre Tregouet; Sandrine Barbaux; Sylvie Escolano; Nadia Tahri; Jean-Louis Golmard; Laurence Tiret; François Cambien
Journal:  Hum Mol Genet       Date:  2002-08-15       Impact factor: 6.150

3.  Perilipin, a major hormonally regulated adipocyte-specific phosphoprotein associated with the periphery of lipid storage droplets.

Authors:  A S Greenberg; J J Egan; S A Wek; N B Garty; E J Blanchette-Mackie; C Londos
Journal:  J Biol Chem       Date:  1991-06-15       Impact factor: 5.157

4.  The murine perilipin gene: the lipid droplet-associated perilipins derive from tissue-specific, mRNA splice variants and define a gene family of ancient origin.

Authors:  X Lu; J Gruia-Gray; N G Copeland; D J Gilbert; N A Jenkins; C Londos; A R Kimmel
Journal:  Mamm Genome       Date:  2001-09       Impact factor: 2.957

5.  Absence of perilipin results in leanness and reverses obesity in Lepr(db/db) mice.

Authors:  J Martinez-Botas; J B Anderson; D Tessier; A Lapillonne; B H Chang; M J Quast; D Gorenstein; K H Chen; L Chan
Journal:  Nat Genet       Date:  2000-12       Impact factor: 38.330

6.  Perilipin ablation results in a lean mouse with aberrant adipocyte lipolysis, enhanced leptin production, and resistance to diet-induced obesity.

Authors:  J T Tansey; C Sztalryd; J Gruia-Gray; D L Roush; J V Zee; O Gavrilova; M L Reitman; C X Deng; C Li; A R Kimmel; C Londos
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-22       Impact factor: 11.205

7.  Genetic versus environmental aetiology of the metabolic syndrome among male and female twins.

Authors:  P Poulsen; A Vaag; K Kyvik; H Beck-Nielsen
Journal:  Diabetologia       Date:  2001-05       Impact factor: 10.122

8.  Perilipin A increases triacylglycerol storage by decreasing the rate of triacylglycerol hydrolysis.

Authors:  D L Brasaemle; B Rubin; I A Harten; J Gruia-Gray; A R Kimmel; C Londos
Journal:  J Biol Chem       Date:  2000-12-08       Impact factor: 5.157

9.  Can dietary factors explain differences in serum cholesterol profiles among different ethnic groups (Chinese, Malays and Indians) in Singapore?

Authors:  M Deurenberg-Yap; T Li; W L Tan; W A van Staveren; S K Chew; P Deurenberg
Journal:  Asia Pac J Clin Nutr       Date:  2001       Impact factor: 1.662

10.  Genetic variation at the perilipin (PLIN) locus is associated with obesity-related phenotypes in White women.

Authors:  L Qi; D Corella; J V Sorlí; O Portolés; H Shen; O Coltell; D Godoy; A S Greenberg; J M Ordovas
Journal:  Clin Genet       Date:  2004-10       Impact factor: 4.438

View more
  25 in total

Review 1.  The role of lipid droplets in metabolic disease in rodents and humans.

Authors:  Andrew S Greenberg; Rosalind A Coleman; Fredric B Kraemer; James L McManaman; Martin S Obin; Vishwajeet Puri; Qing-Wu Yan; Hideaki Miyoshi; Douglas G Mashek
Journal:  J Clin Invest       Date:  2011-06-01       Impact factor: 14.808

Review 2.  Nutrigenomics: integrating genomic approaches into nutrition research.

Authors:  Lynnette R Ferguson
Journal:  Mol Diagn Ther       Date:  2006       Impact factor: 4.074

3.  PLIN1 gene: fat keeper and prevention switcher.

Authors:  José M Ordovás; Caren E Smith
Journal:  J Appl Physiol (1985)       Date:  2010-01-14

4.  Perilipin polymorphism interacts with dietary carbohydrates to modulate anthropometric traits in hispanics of Caribbean origin.

Authors:  Caren E Smith; Katherine L Tucker; Nikos Yiannakouris; Bibiana Garcia-Bailo; Josiemer Mattei; Chao-Qiang Lai; Laurence D Parnell; José M Ordovás
Journal:  J Nutr       Date:  2008-10       Impact factor: 4.798

5.  An Improved PCR-RFLP Assay for the Detection of a Polymorphism rs2289487 of PLIN1 Gene.

Authors:  Xiaolei Feng; Sihua Wang; Xiaoran Duan; Chunyang Li; Zhen Yan; Feifei Feng; Songcheng Yu; Yongjun Wu; Wei Wang
Journal:  J Clin Lab Anal       Date:  2016-04-13       Impact factor: 2.352

6.  Genetic Predictors of ≥5% Weight Loss by Multidisciplinary Advice to Severely Obese Subjects.

Authors:  Erik E J G Aller; Edwin C M Mariman; Freek G Bouwman; Marleen A van Baak
Journal:  J Nutrigenet Nutrigenomics       Date:  2017-06-03

Review 7.  Update on perilipin polymorphisms and obesity.

Authors:  Caren E Smith; José M Ordovás
Journal:  Nutr Rev       Date:  2012-10       Impact factor: 7.110

8.  Effects of perilipin (PLIN) gene variation on metabolic syndrome risk and weight loss in obese children and adolescents.

Authors:  Sophie Deram; Christiane Y Nicolau; Pablo Perez-Martinez; Isabel Guazzelli; Alfredo Halpern; Bernardo L Wajchenberg; Jose M Ordovas; Sandra M Villares
Journal:  J Clin Endocrinol Metab       Date:  2008-09-23       Impact factor: 5.958

9.  Common variations in perilipin gene, central obesity, and risk of type 2 diabetes in US women.

Authors:  Lu Qi; Cuilin Zhang; Andrew Greenberg; Frank B Hu
Journal:  Obesity (Silver Spring)       Date:  2008-03-06       Impact factor: 5.002

10.  Variation in the perilipin gene (PLIN) affects glucose and lipid metabolism in non-Hispanic white women with and without polycystic ovary syndrome.

Authors:  Toshihide Kawai; Maggie C Y Ng; M Geoffrey Hayes; Issei Yoshiuchi; Takafumi Tsuchiya; Heather Robertson; Nancy J Cox; Kenneth S Polonsky; Graeme I Bell; David A Ehrmann
Journal:  Diabetes Res Clin Pract       Date:  2009-09-25       Impact factor: 5.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.